[1]
|
Frank, S. (1995) Polycystic Ovary Syndrome. New England Journal of Medicine, 333, 833-861.
|
[2]
|
Stein, I.F. and Leventhal, M.L. (1934) Amenorrhea Associated with Bilateral Polycystic Ovaries. American Journal of Obstetrics & Gynecology, 29, 181-191.
|
[3]
|
Wild, R.A. (2002) Long-Term Health Consequences of PCOS. Human Reproduction Update, 8, 231-241.
http://dx.doi.org/10.1093/humupd/8.3.231
|
[4]
|
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome. Human Reproduction, 19, 41-47.
|
[5]
|
Hull, M.G. (1987) Epidemiology of Infertility and Polycystic Ovarian Disease: Endocrinological and Demographic Studies. Gynecological Endocrinology, 1, 235-245. http://dx.doi.org/10.3109/09513598709023610
|
[6]
|
Homburg, R., Armar, N.A., Eshel, A., Adams, J. and Jacobs, H.S. (1988) Influence of Serum Luteinizing Hormone Concentrations on Ovulation, Conception and Early Pregnancy Loss in Polycystic Ovary Syndrome. BMJ, 297, 1024-1026. http://dx.doi.org/10.1136/bmj.297.6655.1024
|
[7]
|
Boomsma, C.M., Eijkemans, M.J., Hughes, E.G., Visser, G.H., Fauser, B.C. and Macklon, N.S. (2006) A Meta-Analysis of Pregnancy Outcomes in Women with Polycystic Ovary Syndrome. Human Reproduction Update, 12, 673-683.
http://dx.doi.org/10.1093/humupd/dml036
|
[8]
|
Kim, H., Taylor, A.E. and Barbieri, R.L. (2000) Insulin Sensitizers and Polycystic Ovary Syndrome: Can a Diabetes Medication Treat Infertility? Fertility and Sterility, 73, 1097-1098. http://dx.doi.org/10.1016/S0015-0282(00)00540-9
|
[9]
|
Velazquez, E.M., Mendoza, S., Hamer, T., Sosa, F. and Glueck, C.J. (1994) Metformin Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinemia, Insulin Resistance, Hyperandrogenemia, and Systolic Blood Pressure, While Facilitating Normal Menses and Pregnancy. Metabolism, 43, 647-654.
http://dx.doi.org/10.1016/0026-0495(94)90209-7
|
[10]
|
Bailey, C.S. and Turner, R.C. (1996) Metformin Drug Therapy. New England Journal of Medicine, 334, 574-579.
http://dx.doi.org/10.1056/NEJM199602293340906
|
[11]
|
De Fronzo, R.A., Barzilai, N. and Simonson, D.C. (1991) Mechanism of Metformin Action in Obese and Lean Noninsulin-Dependent Diabetic Subjects. Journal of Clinical Endocrinology and Metabolism, 73, 1294-1301.
http://dx.doi.org/10.1210/jcem-73-6-1294
|
[12]
|
Attia, G.R., Rainey, W.E. and Carr, B.R. (2001) Metformin Directly Inhibits Androgen Production in Human Theca Cells. Fertility and Sterility, 76, 517-524. http://dx.doi.org/10.1016/S0015-0282(01)01975-6
|
[13]
|
Nestler, J.E., Jakubowicz, D.J., Evans, W.S. and Pasquali, R. (1998) Effects of Metformin on Spontaneous and Clomiphene Induced Ovulation in the Polycystic Ovary Syndrome. New England Journal of Medicine, 338, 1876-1880.
http://dx.doi.org/10.1056/NEJM199806253382603
|
[14]
|
Velazquez, E.M., Acosta, A. and Mendoza, S.G. (1997) Menstrual Cyclicity after Metformin Therapy in Polycystic Ovary Syndrome. Obstetrics & Gynecology, 90, 392-395. http://dx.doi.org/10.1016/S0029-7844(97)00296-2
|
[15]
|
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., et al. (2000) Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6 Month Trial, Followed by Open, Long-Term Clinical Evaluation. Journal of Clinical Endocrinology and Metabolism, 85, 139-146.
|
[16]
|
Ehrmann, D.A., Cavaghan, M.K., Imperial, J., Sturis, J., Rosenfield, R.L. and Polonsky, K.S. (1997) Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 524-530.
|
[17]
|
Sahin, Y., Yirmibes, U., Kelestimur, F. and Aygen, E. (2004) The Effects of Metformin on Insulin Resistance, Clomiphene-Induced Ovulation and Pregnancy Rates in Women with Polycystic Ovary Syndrome. European Journal of Obstetrics, Gynecology and Reproductive Biology, 113, 214-220.
|
[18]
|
Norman, R.J. (2004) Metformin—Comparison with Other Therapies in Ovulation Induction in Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism, 89, 4797-4800. http://dx.doi.org/10.1210/jc.2004-1658
|
[19]
|
Badawy, A., Mosbah, A., Tharwat, A. and Eid, M. (2009) Extended Letrozole Therapy for Ovulation Induction in Clomiphene-Resistant Women with Polycystic Ovary Syndrome: A Novel Protocol. Fertility and Sterility, 92, 236-239. http://dx.doi.org/10.1016/j.fertnstert.2008.04.065
|
[20]
|
Kar, S. (2012) Clomiphene Citrate or Letrozole as First-Line Ovulation Induction Drug in Infertile PCOS Women: A Prospective Randomized Trial. Journal of Human Reproductive Sciences, 5, 262-265.
http://dx.doi.org/10.4103/0974-1208.106338
|
[21]
|
Elizur, S.E. and Tulandi, T. (2008) Drugs in Infertility and Fetal Safety. Fertility and Sterility, 89, 1595-1602.
http://dx.doi.org/10.1016/j.fertnstert.2008.02.092
|
[22]
|
Buttram Jr., V.C. and Vacquero, C. (1975) Postovarian Wedge Resection Adhesive Disease. Fertility and Sterility, 26, 874-876.
|
[23]
|
Gjonnaess, H. (1984) Polycystic Ovarian Syndrome Treated by Ovarian Electrocautery through the Laparoscope. Fertility and Sterility, 41, 20-25.
|
[24]
|
Keckstein, J. (1989) Laparoscopic Treatment of Polycystic Ovarian Syndrome in Laparoscopic Surgery. Baillière’s Clinical Obstetrics and Gynaecology, 3, 563-581. http://dx.doi.org/10.1016/S0950-3552(89)80009-4
|
[25]
|
Lord, J.M., Flight, I.H.K. and Norman, R.J. (2003) Metformin in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. British Medical Journal, 327, 951-953. http://dx.doi.org/10.1136/bmj.327.7421.951
|
[26]
|
Lord, J.M., Flight, I.H.K. and Norman, R.J. (2003) Insulin-Sensitising Drugs (Metformin, Troglitazone, Rosiglitazone, Pioglitazone, D-Chiro-Inositol) for Polycystic Ovarian Syndrome. Cochrane Database of Systematic Reviews, 2003, Article ID: CD003053.
|
[27]
|
Mitwally, M.F.M. and Casper, R.F. (2002) Aromatase Inhibition for Ovarian Stimulation: Future Avenues for Infertility Management. Current Opinion in Obstetrics & Gynecology, 14, 255-263.
http://dx.doi.org/10.1097/00001703-200206000-00003
|
[28]
|
Hsu, M.I., Liou, T.H., Chou, S.Y., Chang, C.Y. and Hsu, C.S. (2007) Diagnostic Criteria for Polycystic Ovary Syndrome in Taiwanese Chinese Women: Comparison between Rotterdam 2003 and NIH 1990. Fertility and Sterility, 88, 727-729. http://dx.doi.org/10.1016/j.fertnstert.2006.11.149
|
[29]
|
Aruna, J., Mittal, S., Kumar, S., Misra, R., Dadhwal, V. and Vimala, N. (2004) Metformin Therapy in Women with Polycystic Ovary Syndrome. International Journal of Gynaecology and Obstetrics, 87, 237-241.
|
[30]
|
Sugimoto, O. and Aono (1993) The Committee for Reproductive and Endocrine in Japan Society of Obstetrics and Gynaecology. Annual Report (1991-1992) for the Determination of Diagnostic Criteria for PCOS. Acta Obstetrica et Gynaecologica Japonica, 45, 1359-1367.
|
[31]
|
Nestler, J.E. and Jakubowicz, D.J. (1996) Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome. New England Journal of Medicine, 335, 617-623. http://dx.doi.org/10.1056/NEJM199608293350902
|
[32]
|
Fleming, R., Hopkinson, Z.E., Wallace, A.M., Greer, I.A. and Sattar, N. (2002) Ovarian Function and Metabolic Factors in Women with Oligomenorrhea Treated with Metformin in a Randomized Double Blind Placebo-Controlled Trial. Journal of Clinical Endocrinology & Metabolism, 87, 569-574. http://dx.doi.org/10.1210/jcem.87.2.8261
|
[33]
|
Balen, A. (2000) Ovulation Induction for Polycystic Ovary Syndrome. Fertility and Sterility, 3, 106-111.
|